• OPEN AN ACCOUNT
Indian Indices
Nifty
15,752.05 -28.20
(-0.18%)
Sensex
52,907.93 -111.01
( -0.21%)
Bank Nifty
33,539.45 114.35
( 0.34%)
Nifty IT
28,064.25 220.90
( 0.79%)
Global Indices
Nasdaq
11,127.85 99.11
(0.90%)
Dow Jones
31,097.26 321.83
(1.05%)
Hang Seng
21,859.79 -137.10
(-0.62%)
Nikkei 225
25,935.62 -457.42
(-1.73%)
Forex
USD-INR
78.74 0.00
(0.00%)
EUR-INR
82.59 0.00
(0.00%)
GBP-INR
95.74 0.00
(0.00%)
JPY-INR
0.58 0.00
(0.00%)

EQUITY - MARKET SCREENER

Tata Communications Ltd
Industry :  Telecommunications - Service Provider
BSE Code
ISIN Demat
Book Value()
500483
INE151A01013
343.9519298
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
TATACOMM
23.05
26623.28
EPS(TTM)
Face Value()
Div & Yield %
40.52
10
2.22
 

Oxygenta Pharmaceutical reports standalone net loss of Rs 0.91 crore in the March 2022 quarter
May 20,2022
Net loss of Oxygenta Pharmaceutical reported to Rs 0.91 crore in the quarter ended March 2022 as against net profit of Rs 0.81 crore during the previous quarter ended March 2021. Sales declined 36.16% to Rs 7.08 crore in the quarter ended March 2022 as against Rs 11.09 crore during the previous quarter ended March 2021.

For the full year,net loss reported to Rs 0.61 crore in the year ended March 2022 as against net profit of Rs 2.93 crore during the previous year ended March 2021. Sales rose 16.32% to Rs 60.52 crore in the year ended March 2022 as against Rs 52.03 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear Ended
 Mar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.
Sales7.0811.09 -36 60.5252.03 16
OPM %-20.344.60 -2.437.34 -
PBDT-1.59-0.74 -115 0.552.13 -74
PBT-1.97-1.17 -68 -1.040.93 PL
NP-0.910.81 PL -0.612.93 PL